Express Pharma

Mankind Pharma to adopt SoftLayer’s cloud platform

0 104

IBM announced that Mankind Pharma has selected SoftLayer’s cloud platform to support its business growth and expansion. SoftLayer, an IBM company, will enable Mankind Pharma to significantly improve the performance of its business critical applications and scale the use of these applications across multiple locations.

SoftLayer’s infrastructure was chosen as the ideal solution to fit the business needs of Mankind Pharma. It ensured scalability of the infrastructure depending on Mankind Pharma’s changing business needs. Since these business critical applications are designed to meet the growing needs of its key stakeholders, it becomes mission-critical for Mankind Pharma to deploy the right amount of compute to run seamless operations. SoftLayer cloud provided the perfect combination of pay-as-you-use option as well as scalability to suit business need.

“We chose SoftLayer as a service which helped us deploy our business critical application on Cloud which required a highly scalable infrastructure to meet the ongoing demands of the market. SoftLayer is geared to meet these requirements and help us continue our strong business momentum and provide greater client satisfaction,” said Pramod Gokhale, Vice President-Information Services & Strategy, Mankind Pharma.

Apart from scaling operations during peak months, the SoftLayer infrastructure will also help Mankind Pharma scale up quickly when it expands operations to international markets.

“IBM has been a strategic partner of Mankind Pharma for a long time and it is exciting to see our engagement is expanding on to cloud. With SoftLayer, IBM is focused on providing higher value and delivering unmatched expertise and capabilities to help clients tackle business specific challenges with cloud. With SoftLayer cloud, Mankind Pharma can have a better control on their operations to drive business growth,” said Ganesh Margabandhu, General Manager, Global Technology Services, IBM India South Asia.

EP News BureauMumbai

- Advertisement -

Leave A Reply

Your email address will not be published.